Arginase type I as a marker of coronary heart disease in hemodialysis patients

@article{Eleftheriadis2010ArginaseTI,
  title={Arginase type I as a marker of coronary heart disease in hemodialysis patients},
  author={Theodoros Eleftheriadis and Vassilios Liakopoulos and Georgia Antoniadi and Ioannis Stefanidis and Grammati Galaktidou},
  journal={International Urology and Nephrology},
  year={2010},
  volume={43},
  pages={1187-1194}
}
Cardiovascular disease, and mainly coronary heart disease (CHD), is the leading cause of death in hemodialysis (HD) patients. Non-traditional risk factors may play an important role in this population. Arginase is known to contribute directly to atherosclerosis progression and to counteract the beneficial effects of nitric oxide. HD could be considered as an inflammatory condition. Inflammation contributes to atherosclerosis progression and influences both arginase and nitric oxide synthase… CONTINUE READING
6 Citations
47 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-6 of 6 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 47 references

Similar Papers

Loading similar papers…